1. Home
  2. PHAR vs TIXT Comparison

PHAR vs TIXT Comparison

Compare PHAR & TIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • TIXT
  • Stock Information
  • Founded
  • PHAR 1988
  • TIXT 2005
  • Country
  • PHAR Netherlands
  • TIXT Canada
  • Employees
  • PHAR N/A
  • TIXT N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • TIXT EDP Services
  • Sector
  • PHAR Health Care
  • TIXT Technology
  • Exchange
  • PHAR Nasdaq
  • TIXT Nasdaq
  • Market Cap
  • PHAR 587.5M
  • TIXT 694.9M
  • IPO Year
  • PHAR N/A
  • TIXT 2021
  • Fundamental
  • Price
  • PHAR $10.03
  • TIXT $2.68
  • Analyst Decision
  • PHAR Strong Buy
  • TIXT Hold
  • Analyst Count
  • PHAR 3
  • TIXT 8
  • Target Price
  • PHAR $30.00
  • TIXT $4.44
  • AVG Volume (30 Days)
  • PHAR 3.0K
  • TIXT 222.2K
  • Earning Date
  • PHAR 05-08-2025
  • TIXT 05-09-2025
  • Dividend Yield
  • PHAR N/A
  • TIXT N/A
  • EPS Growth
  • PHAR N/A
  • TIXT N/A
  • EPS
  • PHAR N/A
  • TIXT N/A
  • Revenue
  • PHAR $320,708,000.00
  • TIXT $2,658,000,000.00
  • Revenue This Year
  • PHAR $12.39
  • TIXT $3.72
  • Revenue Next Year
  • PHAR $9.84
  • TIXT $3.63
  • P/E Ratio
  • PHAR N/A
  • TIXT N/A
  • Revenue Growth
  • PHAR 24.13
  • TIXT N/A
  • 52 Week Low
  • PHAR $6.65
  • TIXT $2.13
  • 52 Week High
  • PHAR $11.07
  • TIXT $7.74
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 71.58
  • TIXT 62.58
  • Support Level
  • PHAR $8.60
  • TIXT $2.46
  • Resistance Level
  • PHAR $9.40
  • TIXT $2.64
  • Average True Range (ATR)
  • PHAR 0.28
  • TIXT 0.11
  • MACD
  • PHAR 0.15
  • TIXT 0.05
  • Stochastic Oscillator
  • PHAR 100.00
  • TIXT 86.54

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About TIXT TELUS International (Cda) Inc. Subordinate Voting Shares

TELUS International (Cda) Inc is a digital customer experience innovator that designs, builds, and delivers next-generation solutions. Its clients include companies across several verticals, including Tech and Games, eCommerce and FinTech, Banking, Financial Services and Insurance, Communications and Media, and Healthcare. The solutions offered by the company include Digital Experience, Customer Experience, Advisory Services, and Back Office and Automation among other services. Geographically, it derives a majority of its revenue from the European region.

Share on Social Networks: